What This Immunome Sale Signals Ahead of FDA Milestone
When a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Using index funds for stock diversification can simplify your investment strategy. Explore how they can provide broad market exposure.
23,126 articlesWhen a biotech firm nears a major FDA decision, every insider transaction can feel like a tell. This article dives in...
Insider moves can signal a lot about a company’s near-term plans and risk. This deep dive looks at Adaptive Biotechno...
When a chief executive sells stock, investors ask if the move is a red flag or a routine tax-related step. This piece...
Chevron’s move to explore pipeline routes that bypass the Strait of Hormuz could change oil flows and stock risk prof...
A seasoned investor’s eye looks beyond a single insider trade. This article breaks down why this limited insider sale...
Oil prices surged as geopolitical tensions intensified, sending U.S. equities lower in early March trading. The S&P 5...
Bumble delivered a beat on Q4 2025 revenue as it unveiled Bee, an AI dating concierge. The move coincided with a dram...
A veteran portfolio manager recounts selling a 19-bagger too early and explains how that misstep reshaped his long-te...
Stocks trim gains as a risk-on mood cools. The Nasdaq Composite weakens, while tech names temper their rally as trade...
Jim Cramer cautions that AI stock surges can reverse sharply if earnings fail to accelerate, a warning that comes as ...
Berkshire Hathaway's Greg Abel could be quietly steering a strategic tilt toward AI-enabled winners. This deep dive e...
A bold government push is reshaping quantum tech and investing. Learn which three big stocks are positioned to win, a...